CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zydus Lifesciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zydus Lifesciences Ltd
Zydue Tower, Satellite Cross Road
Phone: +91 7926868100p:+91 7926868100 AHMEDABAD, 382481  India Ticker: ZYDUSLIFEZYDUSLIFE
Business Summary
Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20253/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Pankaj R.Patel 72 7/12/2017 7/12/2017
Chief Financial Officer TusharShroff 55 9/1/2025 9/1/2025
Company Secretary, Compliance Officer Dhaval N.Soni 2/7/2019 2/7/2019
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Amplitude Surgical SA 11, Cours Jacques Offenbach VALENCE France
Sentynl Therapeutics, Inc. 420 Stevens Ave. Solana Beach CA United States
Zydus Animal Health and Investments Limited No. 63, Survey No. 536 , Zydus Corporate Park Ahmedabad Gujarat India
4 additional Subsidiary records available in full report.

Business Names
Business Name
532321
Alidac Healthcare (Myanmar) Limited
Alidac Pharmaceuticals Limited
57 additional Business Names available in full report.

General Information
Number of Employees: 27,917 (As of 3/31/2025)
Outstanding Shares: 1,006,000,000 (As of 9/30/2025)
Shareholders: 379,848
Stock Exchange: NSE
Fax Number: +91 7926862365


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026